Unmasking the Villains of Alzheimer’s Disease
By Greg Kutcher, MD
If you’ve ever loved someone through Alzheimer’s, you know it’s more than a diagnosis—it’s a thief, lurking just out of reach. As one granddaughter put it, it’s “the cruel monster that waited in the shadows of my grandfather.” But here’s the thing: if we’re calling Alzheimer’s the villain, shouldn’t we stop and ask—what kind of villain are we actually up against? And are we even sure we’re aiming at the right target?
Medicine prides itself on logic and precision, but let’s face it: humans love a good story. Give us a struggle, point out the bad guy, and we’re ready to fight. Alzheimer’s fits the role of the perfect villain: sneaky, relentless, and devastating. It’s the Darth Vader of diseases. But when we zero in on a single villain, we risk missing the real plot twist. Disease doesn’t come from just one place. Every villain has a backstory, its own brand of chaos. And when we oversimplify, we miss the rest of the story.
What’s Ahead in This Essay?
The Simplistic Villain: Plaques and Tangles We’ll explore how Alzheimer’s became synonymous with plaques and tangles, and why this narrow focus might be like blaming the henchman while the mastermind escapes.
The Limits of Early Diagnosis We’ll examine the push for early diagnosis and its unintended consequences, from overdiagnosis to treatments that don’t deliver meaningful benefits.
Rethinking Risk Factors and Prevention We’ll discuss the overlooked role of lifestyle factors like inflammation, exercise, and connection, and how they’re reshaping the narrative on Alzheimer’s.
The Neighborhood Model of Disease We’ll consider a broader, holistic approach to understanding disease, one that emphasizes the environment where health and healing thrive.
The Business of Early Diagnosis Finally, we’ll reflect on how the biomedical model and the business of medicine influence our approach to Alzheimer’s—and what we can do differently.
The Broader Lesson: Rethinking Modern Medicine We’ll close by exploring what Alzheimer’s teaches us about modern healthcare and how compassion, connection, and story stewardship can guide us toward better outcomes.
——————————————————————————————————-
The Simplistic Villain: Plaques and Tangles
In 1906, Dr. Alois Alzheimer discovered something strange in his patient’s brain: sticky deposits of amyloid plaques and tangled proteins. Think of plaques as brain-clogging gunk and tau proteins as snarled noodles that choke out normal function. These features became the iconic villains of Alzheimer’s, and ever since, research has been laser-focused on defeating them.
But here’s the twist: researchers still don’t know if plaques and tangles are the cause of Alzheimer’s or a byproduct. Imagine blaming the chalk outline at a crime scene instead of the culprit. Despite this uncertainty, we’ve poured billions into drugs aimed solely at plaques and tangles.
And since 2018, we’ve redefined Alzheimer’s not as dementia but as a continuum of disease—diagnosable with lab and imaging tests before any symptoms appear. You’re healthy, sharp, and living your best life, but then bam! “Congrats, you’ve got pre-symptomatic Alzheimer’s.” How’s that for a mood killer?
The Limits of Early Diagnosis
On paper, diagnosing Alzheimer’s early sounds perfect: find the culprit, take it out, and avoid the damage. Like spotting a grease fire and putting it out before the whole kitchen goes up. But real life? It’s messier.
Not everyone with plaques and tangles develops dementia. Autopsy studies show that up to a third of people with significant plaque buildup never show symptoms. Meanwhile, most people who die with Alzheimer’s dementia also have other types of dementia, like vascular dementia. Fewer than 3% have pathology exclusive to Alzheimer’s.
This means our laser focus on plaques and tangles ignores the bigger picture. Worse, it drives the push for costly drugs with serious risks—like brain swelling and bleeding—that haven’t delivered real-world benefits. Even if we “fix” Alzheimer’s, what about the other causes of dementia that plaques and tangles don’t explain?
It’s like patching a hole in one tire while ignoring the nails in the others—you’re not going far without a flat.
Rethinking Risk Factors and Prevention
Here’s a question: what do the words “risk factors” conjure up for you? Vague threats? Something to worry about but still approach as a role of the dice. That’s how many people see factors like inflammation, stress, smoking, or education. They’re dismissed as “nice to address” but not central to the story.
It’s not just the public—many scientists are also fixated on finding a villain with a smoking gun. It’s a paradox, really. Even with thousands of studies showing that diet, tobacco, lack of exercise, poor sleep, and insulin resistance produce brain-damaging chemicals and diminish cognition, the response often remains, “But we don’t have proof.” This, despite overwhelming evidence that stopping smoking, staying socially connected, and bringing diabetes or high blood pressure under control slows the decline and prevents Alzheimer’s dementia. Somehow, “risk factors” are seen as the understudies, not the lead actors in this story.
Yet, these so-called “risk factors” have massive impacts. For example, regular exercise alone might reduce the risk of Alzheimer’s dementia by a whopping 45%. That’s not a side note—it’s a headline. And the good news? We’re already seeing evidence of this.
In six North American and European countries, the per capita incidence of Alzheimer’s has declined by over 30% since 1998. Think about that: while the total number of cases rises due to aging populations, individuals today are significantly less likely to develop Alzheimer’s than they were twenty years ago. Why? Likely because of better education, healthier lifestyles, and improved management of conditions like high blood pressure and diabetes. All the things we supposedly don’t have “proof” actually work.
The Neighborhood Model of Disease
Most chronic diseases—including Alzheimer’s—don’t have a single cause. They’re shaped by the “neighborhood” within our bodies: inflammation, stress, and the biological environment that either fosters health or promotes disease. It’s not as simple as finding one villain and taking it out. It’s about creating an environment where healing can thrive.
This idea isn’t new, but it’s unfamiliar. We instinctively know that clean air, purpose, and meaningful connections are good for us. What’s harder is imagining this concept applied internally—how our “biological neighborhood” affects disease and healing. The good news? Science backs this up. Chronic inflammation, for instance, damages brain cells and drives Alzheimer’s. Addressing this can make a tangible difference.
The Business of Early Diagnosis
Why are we so focused on diagnosing Alzheimer’s earlier and earlier? Part of the answer lies in the current business model of medicine. Early diagnosis means lifelong treatment—and enormous profits. Imagine a drug costing tens of thousands of dollars, prescribed before any symptoms appear. That’s a pharmaceutical dream.
But this isn’t just about profit. The biomedical model, with its singular focus on villains and fixes, reinforces this approach. It’s easier to tell a story about slaying a dragon than to advocate for systemic changes like reducing stress or fostering community. And while these approaches may lack the drama of a blockbuster drug, their benefits are undeniable—and affordable.
The Broader Lesson: Rethinking Modern Medicine
The story of Alzheimer’s is more than a cautionary tale about one disease—it’s a spotlight on how we approach medical care as a whole. Our heavy-handed focus on Alzheimer’s, promoting risky drugs with no proven value while insisting there’s “no proof” that holistic approaches work, is a familiar pattern. It feels outdated, like the 1950s and 60s when scientists resisted the clear link between tobacco and lung cancer because it didn’t fit the prevailing model of infectious disease.
The practical takeaway is clear: the same blind spots and biases shape how we tackle many modern diseases, from cancer to heart disease to diabetes. We overlook opportunities to prevent and heal using all the tools at our disposal—not because the tools don’t work, but because they challenge the conventional narrative of what medicine should look like. Recognizing this pattern isn’t just useful; it’s essential.
And central to this shift is prioritizing compassion, connection, and story stewardship. These aren’t just “extras” in healthcare—they’re powerful forces that help us see the whole person, foster healing, and build resilience. By questioning old assumptions and embracing a more holistic perspective, we can rewrite the story—not just for Alzheimer’s, but for healthcare as a whole.
_______________________________________________________________________________
Download our free guide here: